2-(1-(4-bromophenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)phenol

ID: ALA5198799

PubChem CID: 168286429

Max Phase: Preclinical

Molecular Formula: C21H13BrF3N3O2

Molecular Weight: 476.25

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Oc1cc(C(F)(F)F)ccc1-c1nc(-c2ccccc2O)n(-c2ccc(Br)cc2)n1

Standard InChI:  InChI=1S/C21H13BrF3N3O2/c22-13-6-8-14(9-7-13)28-20(16-3-1-2-4-17(16)29)26-19(27-28)15-10-5-12(11-18(15)30)21(23,24)25/h1-11,29-30H

Standard InChI Key:  HMIUMTZYUDQYNP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0844   -0.8269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5829   -0.3420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    0.4427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4970    0.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7519   -0.3420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9096    1.1573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4972    1.8721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9092    2.5843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7347    2.5843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1465    1.8739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7383    1.1573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3800   -0.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5938   -1.3526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3888   -1.5648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9724   -0.9812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7614   -0.1876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9661    0.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7525    0.8274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    1.8721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1472    3.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9724    3.2989    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1472    4.1256    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4326    3.7115    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0844   -1.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7990   -2.0650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7983   -2.8877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -3.3004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6284   -2.8912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6332   -2.0665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -4.1256    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  4  1  0
  7  6  2  0
  8  7  1  0
  9  8  2  0
 10  9  1  0
  6 11  1  0
 11 10  2  0
 12  2  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 12 17  1  0
 17 16  2  0
 17 18  1  0
  7 19  1  0
  9 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 24  1  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 24 29  1  0
 29 28  2  0
 27 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5198799

    ---

Associated Targets(Human)

HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.25Molecular Weight (Monoisotopic): 475.0143AlogP: 5.79#Rotatable Bonds: 3
Polar Surface Area: 71.17Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.61CX Basic pKa: CX LogP: 6.82CX LogD: 6.61
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.39Np Likeness Score: -1.10

References

1. Lao Y, Wang Y, Chen J, Huang P, Su R, Shi J, Jiang C, Zhang J..  (2022)  Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.,  236  [PMID:35390713] [10.1016/j.ejmech.2022.114315]

Source